Pharmacyclics, Inc.
Records under this name other than the patents Pharmacyclics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 123 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,954,567 | Mutations Associated with Resistance to Inhibitors of Bruton's Tyrosine Kinase (BTK) now held by Cornell University In force · High confidence | In force | High confidence | |
| US 10,105,552 | Formulations of Histone Deacetylase Inhibitor and Uses Thereof Lapsed on the fee record Ended Oct 23, 2026 · Low confidence | Lapsed on the fee record | Ended Oct 23, 2026 | Low confidence |
| US 8,603,521 | Formulations of Histone Deacetylase Inhibitor and Uses Thereof Lapsed on the fee record Ended Dec 10, 2025 · High confidence | Lapsed on the fee record | Ended Dec 10, 2025 | High confidence |
| US 7,276,612 | Novel Hydroxamates as Therapeutic Agents Term ended Term ended Aug 20, 2025 · High confidence | Term ended | Term ended Aug 20, 2025 | High confidence |
| US 8,415,328 | Factor Viia Inhibitor Term ended Term ended Jun 2, 2025 · High confidence | Term ended | Term ended Jun 2, 2025 | High confidence |
| US 8,729,117 | Factor Viia Inhibitor Term ended Term ended Jun 2, 2025 · High confidence | Term ended | Term ended Jun 2, 2025 | High confidence |
| US 9,181,280 | Factor Viia Inhibitor Term ended Term ended Jun 2, 2025 · High confidence | Term ended | Term ended Jun 2, 2025 | High confidence |
| US 8,410,263 | High-Purity Texaphyrin Metal Complexes now held by University of Texas Lapsed on the fee record Ended Apr 2, 2025 · High confidence | Lapsed on the fee record | Ended Apr 2, 2025 | High confidence |
| US 7,420,089 | Novel Hydroxamates as Therapeutic Agents Term ended Term ended Apr 6, 2024 · High confidence | Term ended | Term ended Apr 6, 2024 | High confidence |
| US 7,482,466 | Novel Hydroxamates as Therapeutic Agents Term ended Term ended Apr 6, 2024 · High confidence | Term ended | Term ended Apr 6, 2024 | High confidence |